Verona Pharma (VRNA)
49.89
1.45 (2.99%)
At close: Jan 15, 2025, 12:32 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| PE Ratio | -28.98 | -25.15 | -7.15 | -3.53 | -1.36 | -39.36 | -36.17 | -3.70K | -1.05K | -2.19K | -836.21 | -782.05 | -988.7 | -883.14 | -870.35 | -1.20K | -507.97 | -558.65 | 9.79K |
| PS Ratio | n/a | 3.77K | 9.94 | n/a | 24.28K | 357.12K | 544.19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 6.32 | 7.50 | 2.69 | 1.24 | 1.29 | 12.45 | 9.28 | 538.39 | 1.40K | 478.41 | 1.02K | 756.11 | 419.79 | 484.43 | 310.51 | 412.47 | 214.06 | 87.14 | 260.07 |
| P/FCF Ratio | -31.38 | -28.85 | -11.95 | -5.09 | -1.28 | -42.62 | -35.45 | -3.25K | -1.20K | -1.60K | -976.44 | -757.09 | -1.06K | -978.22 | -846.01 | -1.20K | -505.89 | -928.03 | 127.31K |
| P/OCF Ratio | -31.38 | -28.87 | -11.95 | -5.1 | -1.29 | -43.25 | -35.82 | -3.32K | -1.23K | -1.70K | -1.03K | -779.44 | -1.08K | -1.01K | -859.07 | -1.22K | -513.03 | -967.69 | 127.31K |
| OCF/S Ratio | n/a | -130.7 | -0.83 | n/a | -18.86K | -8.26K | -15.19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.21 | 0.05 | 0.04 | 0.03 | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 33.33 | 12.64 | 4.97 | 13.94 | 3.98 | 7.01 | 10.13 | 4.03 | 3.07 | 21.47 | 1.74 | 5.86 | 17.36 | 10.39 | 12.52 | 30.85 | 11.04 | 36.61 | 82.75 |
| Current Ratio | 33.33 | 12.77 | 5.09 | 14.26 | 4.26 | 7.01 | 10.13 | 4.03 | 3.07 | 21.47 | 1.74 | 5.86 | 16.78 | 10.06 | 11.19 | 30.04 | 9.51 | 36.61 | 82.58 |
| Asset Turnover | n/a | 0.00 | 0.21 | n/a | 0.00 | 0.00 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -32.85 | -126.9 | -215.63 | -2.12K | -243.09 | n/a | -407.62 | -82.87 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.22 | -0.3 | -0.38 | -0.35 | -0.94 | -0.32 | -0.26 | -0.15 | -1.33 | -0.22 | -1.22 | -0.97 | -0.42 | -0.55 | -0.36 | -0.34 | -0.42 | -0.16 | 0.03 |
| Return on Assets (ROA) | -0.18 | -0.26 | -0.3 | -0.32 | -0.71 | -0.27 | -0.23 | -0.11 | -1 | -0.21 | -0.99 | -0.9 | -0.41 | -0.52 | -0.34 | -0.34 | -0.4 | -0.15 | 0.03 |
| Return on Capital (ROIC) | -0.23 | -0.27 | -0.48 | -0.39 | -1.16 | -0.4 | -0.37 | -0.2 | -1.61 | -0.3 | -1.36 | -0.99 | -0.46 | -0.55 | -0.36 | -0.37 | -0.45 | -0.17 | -0.01 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | 24.45% | 100.00% | n/a | -21.68K% | 100.00% | 100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | -15.00K% | -138.92% | n/a | -1.78M% | -907.38K% | -1.50K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | -14.94K% | -138.97% | n/a | -2.19M% | -1.10M% | -1.85K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | -14.44K% | -183.28% | n/a | -2.29M% | -1.17M% | -2.18K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | -13.08K% | -83.17% | n/a | -1.90M% | -837.99K% | -1.54K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | -14.69K% | -105.47% | n/a | -1.37M% | -916.21K% | -1.61K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |